Accueil / Cybersecurite / Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform

Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform

The launch follows the acquisition of catalog’s assets and the appointment of Laurent Guengant as CEO earlier this year.

Origine de l’article : lire l’article original
Traduction